| Financial Year |
March 31 2023 |
| Monetary Funds |
1,059,723,912.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,041,493.49 |
| Accounts Receivable |
120,863,746.61 |
| Advances to Suppliers |
22,373,510.34 |
| Other Receivables |
75,908,363.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
223,512,762.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,815,624.21 |
| Total Current Assets |
1,510,804,252.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
98,481,983.60 |
| Investment Properties |
18,493,884.63 |
| Fixed Assetes |
515,226,607.18 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,950,195.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,334,660.97 |
| Deferred Income Tax Assets |
27,663,445.53 |
| Other Non-Current Assets |
3,290,948.06 |
| Sub-Total of Non-Current Assets |
869,740,751.54 |
| Total Assets |
2,380,545,004.04 |
| Short-Term Loans |
3,050,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
257,218,969.57 |
| Accounts Payable |
168,355,984.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,807,204.49 |
| Taxes Payable |
30,123,618.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
73,334,011.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,675,794.61 |
| Other Current Liabilities |
13,712,089.52 |
| Sub-Total of Current Liabilities |
671,257,311.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,079,382.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
65,110,415.36 |
| Total Liabilities |
736,367,726.75 |
| Paid-In Capital(Or Share Stock) |
401,700,000.00 |
| Capital Surplus |
726,782,731.71 |
| Surplus Reserve |
106,693,481.74 |
| LESS:Treasury Stock |
153,352,953.86 |
| Undistributed Profits |
476,490,361.94 |
| Minority Stockholder's Interest |
51,413,820.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,592,763,457.17 |
| Owner's Equity（Stockholder's Equity） |
1,644,177,277.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,380,545,004.04 |
